New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

By Stephanie Nolen Stephanie Nolen has reported on U.S.A.I.D.-funded clinical trials in more ... level of the drug in their bodies to prevent H.I.V. infection. Without regular injections, or ...

The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...